BlackRock Investment Management’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$237K Hold
1,568
﹤0.01% 3209
2016
Q3
$507K Sell
1,568
-5
-0.3% -$1.82K ﹤0.01% 3038
2016
Q2
$513K Buy
1,573
+83
+6% +$28.6K ﹤0.01% 3055
2016
Q1
$499K Buy
1,490
+32
+2% +$10.9K ﹤0.01% 2905
2015
Q4
$567K Buy
1,458
+20
+1% +$7.83K ﹤0.01% 2954
2015
Q3
$589K Buy
1,438
+237
+20% +$124K ﹤0.01% 2952
2015
Q2
$877K Buy
1,201
+1,144
+2,007% +$811K ﹤0.01% 2869
2015
Q1
$28K Buy
57
+13
+30% +$5.55K ﹤0.01% 3378
2014
Q4
$14K Hold
44
﹤0.01% 3548
2014
Q3
$15K Hold
44
﹤0.01% 3504
2014
Q2
$11K Buy
+44
New +$14.1K ﹤0.01% 3593

Other funds holding CRDF

BlackRock Investment Management's CRDF Position: Q4 2016 in Review

BlackRock Investment Management held its Cardiff Oncology (CRDF) position steady in Q4 2016 at 1,568 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #3209.

BlackRock Investment Management first reported a position in CRDF in Q2 2014 and has held it in 11 quarters since. The position peaked at $877K in Q2 2015. 68 funds tracked by Wall St. Rank hold CRDF as of Q4 2016.

  • BlackRock Investment Management held 1,568 shares of Cardiff Oncology worth $237K as of Q4 2016.
  • BlackRock Investment Management left its Cardiff Oncology share count unchanged in Q4 2016.
  • Cardiff Oncology made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3209 holding.
  • BlackRock Investment Management first reported a position in Cardiff Oncology in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Investment Management's Cardiff Oncology position peaked at $877K in Q2 2015.
  • 68 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.